Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose esketamine for painless gastrointestinal endoscopy
ChiCTR2100048556Phase 4Not yet recruiting
- Sponsor
- Rizhao Central Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine (4 arms), sponsored by Rizhao Central Hospital. Primary endpoints: Anesthesia effect, Respiratory changes and 4 more. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2100048556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048556.